SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-207438
Filing Date
2013-05-08
Accepted
2013-05-08 16:07:33
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d501388d10q.htm 10-Q 690000
2 EX-31.1 d501388dex311.htm EX-31.1 6531
3 EX-31.2 d501388dex312.htm EX-31.2 6527
4 EX-32.1 d501388dex321.htm EX-32.1 3434
5 EX-32.2 d501388dex322.htm EX-32.2 3430
  Complete submission text file 0001193125-13-207438.txt   4947609

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tsrx-20130331.xml EX-101.INS 691536
7 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20130331.xsd EX-101.SCH 49831
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20130331_cal.xml EX-101.CAL 48500
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsrx-20130331_def.xml EX-101.DEF 169346
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20130331_lab.xml EX-101.LAB 370424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20130331_pre.xml EX-101.PRE 277655
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 13824564
SIC: 2834 Pharmaceutical Preparations